Tema Oncology ETF Rating $26.06 +0.28 (+1.07%) Closing price 03:34 PM EasternExtended Trading$26.08 +0.03 (+0.12%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Tema Oncology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.CANC Aggregate RatingModerate Buy 2.81Holdings in CANC have an aggregate rating of Moderate Buy based on 571 analyst ratings issued in the past year covering 45 companies (87.5% of the portfolio).CANC Aggregate Price Target$26.06High Prediction$26.06Average Prediction$26.06Low Prediction$26.06Holdings in CANC have an aggregate price target of $26.06 and a range of $26.06 to $26.06 covering 45 companies (87.5% of the portfolio).CANC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy19 Buy rating(s)Moderate Buy20 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Tema Oncology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 45 CANC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.26%RHHBYRoche$41.30+1.1%N/A2.5775.12%LLYEli Lilly and Company$790.23+0.4%4.9817 of 5 stars2.75$1,012.22 28.1%20Trending NewsAnalyst ForecastOptions VolumeAnalyst Revision4.81%RVMDRevolution Medicines$38.53+0.0%4.5079 of 5 stars3.00$68.00 76.5%11News CoveragePositive News4.57%BBIOBridgeBio Pharma$46.31+0.7%4.6964 of 5 stars3.00$58.93 27.2%14Analyst Upgrade4.05%EXELExelixis$45.23+2.6%4.7079 of 5 stars2.48$44.72 -1.1%21Analyst ForecastOptions Volume3.75%MRUSMerus$55.11+1.1%2.1081 of 5 stars3.14$84.64 53.6%14Positive News3.65%GMABGenmab A/S$21.83+1.1%4.1764 of 5 stars2.67$37.80 73.2%12News CoveragePositive NewsAnalyst Forecast3.52%BMYBristol Myers Squibb$48.54+1.8%4.9258 of 5 stars2.32$57.69 18.8%22Positive NewsAnalyst ForecastAnalyst Revision3.51%NUVLNuvalent$81.97+0.6%3.8058 of 5 stars3.17$119.60 45.9%123.45%AMGNAmgen$300.37+1.3%4.54 of 5 stars2.35$307.82 2.5%23Positive NewsAnalyst Revision3.32%SMMTSummit Therapeutics$25.97+5.0%2.4866 of 5 stars2.79$34.67 33.5%143.09%ACLXArcellx$68.84-0.2%2.3449 of 5 stars3.07$111.23 61.6%152.87%ZLABZai Lab$34.09-4.4%3.3007 of 5 stars2.80$54.28 59.2%5Gap Down2.80%LEGNLegend Biotech$39.79+0.8%2.9162 of 5 stars2.91$72.70 82.7%11Analyst Forecast2.60%MRKMerck & Co., Inc.$84.10+0.5%4.9977 of 5 stars2.43$108.69 29.2%21Trending NewsAnalyst ForecastAnalyst Revision2.59%ONCBeOne Medicines$252.72-1.2%3.3899 of 5 stars3.00$320.67 26.9%62.10%IDYAIDEAYA Biosciences$22.81-0.7%3.4123 of 5 stars2.85$47.55 108.5%13News CoverageAnalyst Upgrade1.88%ABBVAbbVie$194.83+2.2%4.7974 of 5 stars2.81$211.29 8.4%27Trending NewsAnalyst Revision1.69%CGONCG Oncology$27.17+0.5%2.3802 of 5 stars3.00$56.80 109.0%12Analyst Forecast1.65%JANXJanux Therapeutics$25.43-0.2%1.4235 of 5 stars3.09$95.25 274.5%111.41%REGNRegeneron Pharmaceuticals$559.67+1.3%4.9526 of 5 stars2.80$813.52 45.4%25Trending NewsAnalyst ForecastAnalyst Revision1.40%GILDGilead Sciences$114.52+1.1%4.8349 of 5 stars2.77$111.38 -2.7%26Trending NewsAnalyst Revision1.39%ARGXargenex$563.32+1.5%4.3431 of 5 stars3.10$728.06 29.2%21Analyst Upgrade1.39%NRIXNurix Therapeutics$12.72-3.5%1.6139 of 5 stars2.83$30.12 136.8%18Trending NewsEarnings ReportAnalyst ForecastGap UpHigh Trading Volume1.37%IMNMImmunome$8.95+0.7%1.996 of 5 stars3.00$23.33 160.7%61.20%COGTCogent Biosciences$10.87+4.6%2.5956 of 5 stars2.82$17.60 61.9%11Trending NewsAnalyst ForecastOptions VolumeAnalyst RevisionHigh Trading Volume1.07%SNDXSyndax Pharmaceuticals$9.81+6.1%3.3168 of 5 stars2.90$34.30 249.8%10News CoverageAnalyst ForecastGap Up1.00%DAWNDay One Biopharmaceuticals$7.20+2.8%1.7162 of 5 stars3.14$29.00 303.1%71.00%IMCRImmunocore$35.42+2.4%1.6919 of 5 stars2.55$58.89 66.3%110.92%ZYMEZymeworks$13.66+0.6%2.1372 of 5 stars2.90$21.00 53.8%100.92%ELVNEnliven Therapeutics$22.77+5.5%2.7098 of 5 stars3.00$41.20 80.9%5Insider Trade0.92%HCMHUTCHMED$16.02-1.7%1.7044 of 5 stars2.00$19.00 18.6%20.85%AAPGAscentage Pharma Group International$40.60-3.0%N/A3.001News Coverage0.78%GHGuardant Health$51.29+0.5%3.7561 of 5 stars3.00$53.76 4.8%210.76%ARVNArvinas$7.91-3.9%3.5759 of 5 stars2.55$20.29 156.7%22News Coverage0.70%RCUSArcus Biosciences$9.51+1.9%2.5784 of 5 stars2.89$21.29 123.9%9News CoverageGap Up0.67%ILMNIllumina$100.07+2.7%4.8982 of 5 stars2.45$127.16 27.1%20Trending NewsAnalyst Forecast0.54%REPLReplimune Group$10.75+3.4%4.1208 of 5 stars3.13$20.83 93.9%8High Trading Volume0.50%SDGRSchrodinger$21.692.8145 of 5 stars2.75$33.25 53.3%40.48%RLAYRelay Therapeutics$3.74-2.0%2.5569 of 5 stars2.83$17.67 373.0%12Positive News0.45%CGEMCullinan Therapeutics$7.84+0.4%1.8993 of 5 stars3.00$30.00 282.9%5News Coverage0.39%NUVBNuvation Bio$2.32-2.3%3.4741 of 5 stars3.20$7.17 209.6%50.39%AUTLAutolus Therapeutics$2.49+0.6%2.1695 of 5 stars3.00$9.32 275.1%50.37%ANABAnaptysBio$26.05+1.2%2.3106 of 5 stars2.80$42.38 62.7%100.30%CELCCelcuity$13.63+0.9%1.9868 of 5 stars3.17$28.40 108.3%6 This page (NASDAQ:CANC) was last updated on 7/10/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredHow a Kansas farm boy gained 1,285% in two daysA former farm kid placed a simple trade… and cashed out a 1,285% gain two days later. It wasn’t crypto or a...TradeSmith | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting—or plan to collect—Social Security, this could be a game-changer. A new initiative tie...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Oncology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Oncology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
